Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis

Bladder cancer is a heterogeneous disease in molecular, histological and clinical aspects. Treatment should also be considered from different angles - surgery, intravesical chemo- or immunotherapy, radiation therapy and lifestyle changes. Intravesical treatment of superficial bladder cancer with Еpi...

Full description

Saved in:
Bibliographic Details
Main Authors: Boyan Atanasov, Nikolay Nikolov, Vladislav Dunev, Angel Anatoliev, Nikolay Kolev, Martin Stoykov
Format: Article
Language:English
Published: Medical University - Pleven 2022-06-01
Series:Journal of Biomedical & Clinical Research
Subjects:
Online Access:https://jbcr.arphahub.com/article/34623/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849304212011220992
author Boyan Atanasov
Nikolay Nikolov
Vladislav Dunev
Angel Anatoliev
Nikolay Kolev
Martin Stoykov
author_facet Boyan Atanasov
Nikolay Nikolov
Vladislav Dunev
Angel Anatoliev
Nikolay Kolev
Martin Stoykov
author_sort Boyan Atanasov
collection DOAJ
description Bladder cancer is a heterogeneous disease in molecular, histological and clinical aspects. Treatment should also be considered from different angles - surgery, intravesical chemo- or immunotherapy, radiation therapy and lifestyle changes. Intravesical treatment of superficial bladder cancer with Еpirubicin or Bacillus Calmette-Guérin (BCG) is a continuation of surgical treatment to reduce or eliminate further recurrence.
format Article
id doaj-art-9b67e8465e2c45038159eb37b1807b8d
institution Kabale University
issn 1313-9053
language English
publishDate 2022-06-01
publisher Medical University - Pleven
record_format Article
series Journal of Biomedical & Clinical Research
spelling doaj-art-9b67e8465e2c45038159eb37b1807b8d2025-08-20T03:55:48ZengMedical University - PlevenJournal of Biomedical & Clinical Research1313-90532022-06-01151707310.2478/jbcr-2022-000934623Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative AnalysisBoyan AtanasovNikolay NikolovVladislav DunevAngel AnatolievNikolay KolevMartin StoykovBladder cancer is a heterogeneous disease in molecular, histological and clinical aspects. Treatment should also be considered from different angles - surgery, intravesical chemo- or immunotherapy, radiation therapy and lifestyle changes. Intravesical treatment of superficial bladder cancer with Еpirubicin or Bacillus Calmette-Guérin (BCG) is a continuation of surgical treatment to reduce or eliminate further recurrence.https://jbcr.arphahub.com/article/34623/download/pdf/bladder cancerintravesical therapyepirubicin
spellingShingle Boyan Atanasov
Nikolay Nikolov
Vladislav Dunev
Angel Anatoliev
Nikolay Kolev
Martin Stoykov
Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
Journal of Biomedical & Clinical Research
bladder cancer
intravesical therapy
epirubicin
title Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
title_full Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
title_fullStr Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
title_full_unstemmed Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
title_short Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
title_sort intravesical therapy of superficial urothelial bladder cancer with bcg and epirubicin 50 mg comparative analysis
topic bladder cancer
intravesical therapy
epirubicin
url https://jbcr.arphahub.com/article/34623/download/pdf/
work_keys_str_mv AT boyanatanasov intravesicaltherapyofsuperficialurothelialbladdercancerwithbcgandepirubicin50mgcomparativeanalysis
AT nikolaynikolov intravesicaltherapyofsuperficialurothelialbladdercancerwithbcgandepirubicin50mgcomparativeanalysis
AT vladislavdunev intravesicaltherapyofsuperficialurothelialbladdercancerwithbcgandepirubicin50mgcomparativeanalysis
AT angelanatoliev intravesicaltherapyofsuperficialurothelialbladdercancerwithbcgandepirubicin50mgcomparativeanalysis
AT nikolaykolev intravesicaltherapyofsuperficialurothelialbladdercancerwithbcgandepirubicin50mgcomparativeanalysis
AT martinstoykov intravesicaltherapyofsuperficialurothelialbladdercancerwithbcgandepirubicin50mgcomparativeanalysis